There is growing evidence that MTHFR testing has minimal clinical utility, thus American college of medical genetics (ACMG) recommends that it should not be ordered as a part of routine evaluation for thrombophilia [56]. This evidence concerns the gene MTHFR and Rare hereditary thrombophilia.